引用本文: 张温馨,潘宇,李峒作,等.肺癌筛查的卫生经济学评价研究[J].中国卫生经济,2023,42(8):78-81.[点击复制] Zhang Wenxin,Pan Yu,Li Dongzuo,et al.Research on the Health Economic Evaluation of Lung Cancer Screening[J].CHINESE HEALTH ECONOMICS,2023,42(8):78-81.[点击复制]
【打印本页】 查看/发表评论 关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 1117次   下载 708 本文二维码信息
码上扫一扫!
肺癌筛查的卫生经济学评价研究
张温馨,潘宇,李峒作,王亮,马原,寇静恬,唐文祥,迟航
0
(哈尔滨医科大学附属第一医院 哈尔滨 150001)
摘要:
目的:对肺癌筛查进行成本-效果分析,评价肺癌筛查的经济性。方法:构建肺癌筛查决策树模型,对肺癌筛查及不筛查两种策略进行投入产出分析,评价两种策略的成本与健康产出,并进行增量成本-效果分析,判断肺癌筛查策略的经济性。结果:肺癌筛查策略与不筛查策略相比,每多获得1个寿命年的成本为93 153元。结论:根据WHO推荐阈值, 在人群中实施肺癌筛查是具有成本-效果的,应在人群中积极推广肺癌筛查。
关键词:  肺癌筛查  成本-效果分析  决策树模型
DOI:
投稿时间:2023-05-08
基金项目:
Research on the Health Economic Evaluation of Lung Cancer Screening
Zhang Wenxin,Pan Yu,Li Dongzuo,Wang Liang,Ma Yuan,Kou Jingtian,Tang Wenxiang,Chi Hang
(The First Affiliated Hospital of Harbin Medical University, Harbin, 150001 , China)
Abstract:
Objective: Conduct a cost-effectiveness analysis of lung cancer screening to evaluate the economic viability of lung cancer screening. Methods: A decision tree model for lung cancer screening was constructed to analyze the input-output of lung can- cer screening and non-screening strategies, and to evaluate the cost and health outcomes of these two strategies. Incremental cost ef- fectiveness analysis was performed to determine the economics of lung cancer screening strategies. Results: The cost of gaining an additional year of life through lung cancer screening strategy compared to non-screening strategy is 93 153 yuan. Conclusion: Ac- cording to the WHO recommended threshold, implementing lung cancer screening in the population is cost-effective and should be actively promoted.
Key words:  lung cancer screening  cost-effectiveness analysis  decision tree model

用微信扫一扫

用微信扫一扫